Literature DB >> 12239103

Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions.

Vanessa Mynard1, Laurence Guignat, Jocelyne Devin-Leclerc, Xavier Bertagna, Maria Grazia Catelli.   

Abstract

To better understand how leukemia inhibitory factor (LIF) activates proopiomelanocortin (POMC) gene transcription in pituitary corticotrophs, time-course studies of the induction of POMC promoter activity and specific tyrosine phosphorylation of signal transducer and activator of transcription 1 (STAT1) and STAT3 were performed. It was found that both phosphorylation of STAT1 and -3 and activation of the promoter activity rapidly and transiently take place within minutes and 2-6 h, respectively, in favor of a direct effect of the LIF pathway on POMC promoter. Activated STAT1 and -3 form homo-/heterodimers able to bind the Sis-inducible element. The most abundant Sis-inducible element binding dimers are STAT3/3 and STAT1/3. Degenerated STAT1/3-binding sites from the POMC promoter were tested for their ability to bind activated STAT1 and 3; only the -390/-379 site, partially overlapping the Nur response element, binds with low affinity activated STAT1 and -3. Analysis of the three domains and subregions of the POMC promoter showed that two subregions are specifically responsive to LIF. The response of the distal subregion requires the intact STAT1 and -3 DNA-binding site -390/-379, whereas the responsiveness of the proximal subregion takes place despite the absence of direct STAT1 and -3 DNA binding and may imply interaction of activated STAT with basal transcription factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239103     DOI: 10.1210/en.2002-220323

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.

Authors:  Jennifer L Brockman; Linda A Schuler
Journal:  Mol Cell Endocrinol       Date:  2005-07-15       Impact factor: 4.102

2.  A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.

Authors:  David Langlais; Catherine Couture; Guillaume Sylvain-Drolet; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2010-12-30

Review 3.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 4.  The human POMC gene promoter: where do we stand?

Authors:  F Pecori Giraldi; F Cassarino; L Pagliardini; V Asnaghi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

5.  STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.

Authors:  Cuiqi Zhou; Yonghui Jiao; Renzhi Wang; Song-Guang Ren; Kolja Wawrowsky; Shlomo Melmed
Journal:  J Clin Invest       Date:  2015-03-16       Impact factor: 14.808

6.  Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome.

Authors:  Andreas Plagemann; Thomas Harder; Matthias Brunn; Anja Harder; Katharina Roepke; Manon Wittrock-Staar; Thomas Ziska; Karen Schellong; Elke Rodekamp; Kerstin Melchior; Joachim W Dudenhausen
Journal:  J Physiol       Date:  2009-09-01       Impact factor: 5.182

7.  JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats.

Authors:  Melanie Busch-Dienstfertig; Dominika Labuz; Theresa Wolfram; Nicole N Vogel; Christoph Stein
Journal:  Mol Pain       Date:  2012-11-13       Impact factor: 3.395

8.  Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1).

Authors:  Marion Hückel; Uta Schurigt; Andreas H Wagner; Renate Stöckigt; Peter K Petrow; Klaus Thoss; Mieczyslaw Gajda; Steffen Henzgen; Markus Hecker; Rolf Bräuer
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response.

Authors:  David Langlais; Catherine Couture; Aurélio Balsalobre; Jacques Drouin
Journal:  PLoS Genet       Date:  2008-10-17       Impact factor: 5.917

10.  Inhibition of hypothalamic leukemia inhibitory factor exacerbates diet-induced obesity phenotype.

Authors:  Milena Fioravante; Bruna Bombassaro; Albina F Ramalho; Nathalia R Dragano; Joseane Morari; Carina Solon; Natalia Tobar; Celso D Ramos; Licio A Velloso
Journal:  J Neuroinflammation       Date:  2017-09-02       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.